<div class="tables frame-topbot rowsep-0 colsep-0" id="tbl1">
<div class="captions"><span id="cecap50"><p id="spara90"><span class="label">Table 1</span>. Characteristics of the patients at baseline</p></span></div>
<div class="groups"><table>
<thead><tr class="valign-top rowsep-1">
<th scope="col"></th>
<th scope="col"></th>
<th scope="col" class="align-left"><strong>Albiglutide (n=4731)</strong></th>
<th scope="col" class="align-left"><strong>Placebo (n=4732)</strong></th>
</tr></thead>
<tbody>
<tr class="valign-top">
<td class="align-left" colspan="2">Age, years</td>
<td class="align-left">64·1 (8·7)</td>
<td class="align-left">64·2  (8·7)</td>
</tr>
<tr class="valign-top"><td class="align-left" colspan="4">Sex</td></tr>
<tr class="valign-top">
<td></td>
<td class="align-left">Female</td>
<td class="align-left">1427 (30%)</td>
<td class="align-left">1467 (31%)</td>
</tr>
<tr class="valign-top">
<td></td>
<td class="align-left">Male</td>
<td class="align-left">3304 (70%)</td>
<td class="align-left">3265 (69%)</td>
</tr>
<tr class="valign-top"><td class="align-left" colspan="4">Race or ethnicity</td></tr>
<tr class="valign-top">
<td></td>
<td class="align-left">Non-Hispanic white</td>
<td class="align-left">3295 (70%)</td>
<td class="align-left">3288 (69%)</td>
</tr>
<tr class="valign-top">
<td></td>
<td class="align-left">Asian</td>
<td class="align-left">228 (5%)</td>
<td class="align-left">242 (5%)</td>
</tr>
<tr class="valign-top">
<td></td>
<td class="align-left">Non-Hispanic black or African-American</td>
<td class="align-left">111 (2%)</td>
<td class="align-left">114 (2%)</td>
</tr>
<tr class="valign-top">
<td></td>
<td class="align-left">Hispanic</td>
<td class="align-left">1005 (21%)</td>
<td class="align-left">988 (21%)</td>
</tr>
<tr class="valign-top">
<td></td>
<td class="align-left">Other</td>
<td class="align-left">92 (2%)</td>
<td class="align-left">100 (2%)</td>
</tr>
<tr class="valign-top"><td class="align-left" colspan="4">Geographic region</td></tr>
<tr class="valign-top">
<td></td>
<td class="align-left">Western Europe</td>
<td class="align-left">1684 (36%)</td>
<td class="align-left">1708 (36%)</td>
</tr>
<tr class="valign-top">
<td></td>
<td class="align-left">Eastern and central Europe</td>
<td class="align-left">1037 (22%)</td>
<td class="align-left">1010 (21%)</td>
</tr>
<tr class="valign-top">
<td></td>
<td class="align-left">North America</td>
<td class="align-left">967 (20%)</td>
<td class="align-left">978 (21%)</td>
</tr>
<tr class="valign-top">
<td></td>
<td class="align-left">Latin America</td>
<td class="align-left">858 (18%)</td>
<td class="align-left">845 (18%)</td>
</tr>
<tr class="valign-top">
<td></td>
<td class="align-left">Asia Pacific</td>
<td class="align-left">185 (4%)</td>
<td class="align-left">191 (4%)</td>
</tr>
<tr class="valign-top">
<td class="align-left" colspan="2">Current smokers</td>
<td class="align-left">737 (16%)</td>
<td class="align-left">751 (16%)</td>
</tr>
<tr class="valign-top"><td class="align-left" colspan="4">Medical history</td></tr>
<tr class="valign-bottom">
<td></td>
<td class="align-left">Coronary artery disease<a name="btbl1fn1" href="#tbl1fn1" class="workspace-trigger"><sup>*</sup></a>
</td>
<td class="align-left">3333 (70%)</td>
<td class="align-left">3345 (71%)</td>
</tr>
<tr class="valign-top">
<td></td>
<td class="align-left">Hypertension</td>
<td class="align-left">4089 (86%)</td>
<td class="align-left">4095 (87%)</td>
</tr>
<tr class="valign-top">
<td></td>
<td class="align-left">Myocardial infarction</td>
<td class="align-left">2223 (47%)</td>
<td class="align-left">2236 (47%)</td>
</tr>
<tr class="valign-top">
<td></td>
<td class="align-left">Coronary artery bypass surgery</td>
<td class="align-left">890 (19%)</td>
<td class="align-left">842 (18%)</td>
</tr>
<tr class="valign-top">
<td></td>
<td class="align-left">Percutaneous coronary intervention</td>
<td class="align-left">2050 (43%)</td>
<td class="align-left">2113 (45%)</td>
</tr>
<tr class="valign-top">
<td></td>
<td class="align-left">Stroke</td>
<td class="align-left">827 (17%)</td>
<td class="align-left">854 (18%)</td>
</tr>
<tr class="valign-top">
<td></td>
<td class="align-left">Peripheral artery disease</td>
<td class="align-left">1195 (25%)</td>
<td class="align-left">1159 (24%)</td>
</tr>
<tr class="valign-top">
<td></td>
<td class="align-left">Heart failure</td>
<td class="align-left">954 (20%)</td>
<td class="align-left">968 (20%)</td>
</tr>
<tr class="valign-top">
<td></td>
<td class="align-left">Atrial fibrillation</td>
<td class="align-left">394 (8%)</td>
<td class="align-left">392 (8%)</td>
</tr>
<tr class="valign-bottom">
<td class="align-left" colspan="2">Body-mass index, kg/m<sup>2</sup>
</td>
<td class="align-left">32·3 (5·9)</td>
<td class="align-left">32·3 (5·9)</td>
</tr>
<tr class="valign-top"><td class="align-left" colspan="4">Blood pressure, mm Hg</td></tr>
<tr class="valign-top">
<td></td>
<td class="align-left">Systolic</td>
<td class="align-left">134·8 (16·6)</td>
<td class="align-left">134·7 (16·5)</td>
</tr>
<tr class="valign-top">
<td></td>
<td class="align-left">Diastolic</td>
<td class="align-left">76·8 (10·1)</td>
<td class="align-left">76·8 (10·1)</td>
</tr>
<tr class="valign-top">
<td class="align-left" colspan="2">Glycated haemoglobin, %</td>
<td class="align-left">8·76 (1·5)</td>
<td class="align-left">8·72 (1·5)</td>
</tr>
<tr class="valign-bottom">
<td class="align-left" colspan="2">eGFR, mL/min per 1·73 m<sup>2</sup>
</td>
<td class="align-left">79·1 (25·6)</td>
<td class="align-left">78·9 (25·4)</td>
</tr>
<tr class="valign-top">
<td class="align-left" colspan="2">Duration of diabetes, years</td>
<td class="align-left">14·1 (8·6)</td>
<td class="align-left">14·2 (8·9)</td>
</tr>
<tr class="valign-top"><td class="align-left" colspan="4">History of microvascular disease</td></tr>
<tr class="valign-top">
<td></td>
<td class="align-left">Diabetic eye disease</td>
<td class="align-left">982 (21%)</td>
<td class="align-left">955 (20%)</td>
</tr>
<tr class="valign-top">
<td></td>
<td class="align-left">Nephropathy</td>
<td class="align-left">898 (19%)</td>
<td class="align-left">840 (18%)</td>
</tr>
<tr class="valign-top">
<td></td>
<td class="align-left">Peripheral sensory neuropathy</td>
<td class="align-left">1562 (33%)</td>
<td class="align-left">1533 (32%)</td>
</tr>
<tr class="valign-top">
<td></td>
<td class="align-left">Autonomic neuropathy</td>
<td class="align-left">143 (3%)</td>
<td class="align-left">107 (2%)</td>
</tr>
<tr class="valign-top"><td class="align-left" colspan="4">Cardiovascular medications</td></tr>
<tr class="valign-top">
<td></td>
<td class="align-left">Beta-blocker</td>
<td class="align-left">3128 (66%)</td>
<td class="align-left">3182 (67%)</td>
</tr>
<tr class="valign-top">
<td></td>
<td class="align-left">Calcium channel blocker</td>
<td class="align-left">1428 (30%)</td>
<td class="align-left">1431 (30%)</td>
</tr>
<tr class="valign-top">
<td></td>
<td class="align-left">Angiotensin-converting-enzyme inhibitor</td>
<td class="align-left">2263 (48%)</td>
<td class="align-left">2353 (50%)</td>
</tr>
<tr class="valign-top">
<td></td>
<td class="align-left">Angiotensin receptor blocker</td>
<td class="align-left">1599 (34%)</td>
<td class="align-left">1511 (32%)</td>
</tr>
<tr class="valign-top">
<td></td>
<td class="align-left">Thiazide diuretic</td>
<td class="align-left">1089 (23%)</td>
<td class="align-left">1037 (22%)</td>
</tr>
<tr class="valign-top">
<td></td>
<td class="align-left">Loop diuretic</td>
<td class="align-left">895 (19%)</td>
<td class="align-left">899 (19%)</td>
</tr>
<tr class="valign-top">
<td></td>
<td class="align-left">Statin</td>
<td class="align-left">3967 (84%)</td>
<td class="align-left">3988 (84%)</td>
</tr>
<tr class="valign-top">
<td></td>
<td class="align-left">Aspirin</td>
<td class="align-left">3652 (77%)</td>
<td class="align-left">3639 (77%)</td>
</tr>
<tr class="valign-top">
<td></td>
<td class="align-left">P2Y12 inhibitor</td>
<td class="align-left">1224 (26%)</td>
<td class="align-left">1251 (26%)</td>
</tr>
<tr class="valign-top"><td class="align-left" colspan="4">Glucose-lowering medications</td></tr>
<tr class="valign-top">
<td></td>
<td class="align-left">None or diet</td>
<td class="align-left">42 (1%)</td>
<td class="align-left">35 (1%)</td>
</tr>
<tr class="valign-top">
<td></td>
<td class="align-left">Biguanide</td>
<td class="align-left">3463 (73%)</td>
<td class="align-left">3506 (74%)</td>
</tr>
<tr class="valign-top">
<td></td>
<td class="align-left">Sulfonylurea</td>
<td class="align-left">1346 (28%)</td>
<td class="align-left">1379 (29%)</td>
</tr>
<tr class="valign-top">
<td></td>
<td class="align-left">Insulin</td>
<td class="align-left">2860 (60%)</td>
<td class="align-left">2737 (58%)</td>
</tr>
<tr class="valign-top">
<td></td>
<td class="align-left">Dipeptidyl peptidase 4 inhibitor</td>
<td class="align-left">698 (15%)</td>
<td class="align-left">739 (16%)</td>
</tr>
<tr class="valign-top">
<td></td>
<td class="align-left">Sodium-glucose cotransporter 2 inhibitor</td>
<td class="align-left">310 (7%)</td>
<td class="align-left">265 (6%)</td>
</tr>
<tr class="valign-top">
<td></td>
<td class="align-left">Thiazolidinedione</td>
<td class="align-left">92 (2%)</td>
<td class="align-left">102 (2%)</td>
</tr>
<tr class="valign-top">
<td></td>
<td class="align-left">Glinide</td>
<td class="align-left">66 (1%)</td>
<td class="align-left">96 (2%)</td>
</tr>
<tr class="valign-top">
<td></td>
<td class="align-left">α-glucosidase inhibitor</td>
<td class="align-left">34 (1%)</td>
<td class="align-left">37 (1%)</td>
</tr>
</tbody>
</table></div>
<p class="legend"></p>
<p id="spara100">Data are mean (SD) or number (%).</p>
<dl class="footnotes">
<dt id="tbl1fn1">*</dt>
<dd><p id="cenpara10">Any
 of myocardial infarction, coronary artery bypass grafting, percutaneous
 coronary intervention, or at least 50% stenosis of coronary artery on 
angiography. eGFR=estimated glomerular filtration rate.</p></dd>
</dl>
</div>